// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S.
The COVID-19 pandemic exacerbated vulnerabilities in the global medicines supply chain, leading t
by Diana Kwan, Pharm.D., USP Senior Scientist II for Healthcare Quality and Safety